Branded Legacy, Inc. Acquires Spikes CBDx

Branded Legacy, Inc. Acquires MariJ Pharmaceuticals, Inc.

December 4, 2023

Biotechnology

Branded Legacy, Inc. (OTC: BLEG) completed the acquisition of MariJ Pharmaceuticals, Inc., a Clearwater, Florida-based certified-organic CBD extraction and production company, on December 4, 2023. The deal transfers MariJ's mobile CO2 extraction units, licensed vehicles, production lab, IP (including a patent), organic certifications, customer and operational databases, and licenses to Branded Legacy in exchange for preferred series stock and cash.

Branded Legacy, Inc Acquires All In Extracts LLC

January 9, 2024

Biotechnology

Branded Legacy, Inc. (OTC.PK: BLEG), a Melbourne, Florida–based pharmaceutical biotechnology company, has completed the acquisition of All In Extracts LLC, a Tampa, Florida–based medicinal ethnobotany and botanical extracts manufacturer. The deal adds proprietary delivery systems, lab and cultivation capacity (including 800 sq ft of lab space and 16 acres of grow space) to Branded Legacy’s subsidiaries and supports product and capability expansion into supplements and related health-and-wellness markets.

Branded Legacy, Inc. Acquires Sycamore BioPharma, Inc.

March 12, 2024

Biotechnology

Branded Legacy, Inc. (OTC.PK: BLEG) has acquired Sycamore BioPharma, Inc., a developer of plant-based pharmaceuticals, securing more than $2.0 million in assets, including approximately $500,000 of ready-to-sell inventory and key personnel to support clinical development. The deal expands Branded Legacy's manufacturing and extraction capabilities and strengthens its product portfolio and clinical trial resources.

HealthEdge Acquires Legacy-Xspire Holdings, LLC

December 18, 2019

Pharmaceuticals

HealthEdge Investment Partners, a Tampa-based healthcare-focused private equity firm, completed an acquisition of Legacy-Xspire Holdings, LLC, a Ridgeland, Mississippi-based branded and generic pharmaceutical marketing and distribution platform, on December 18, 2019. The deal adds a pharmaceutical marketing and distribution capability (combining WraSer Pharmaceuticals, Gentex Pharma, and Xpsire Pharma) to HealthEdge's portfolio to support organic growth and product acquisitions across the U.S.

Scandia Inc. Acquires Majority Stake in Xtreme Organics Inc.

June 17, 2021

Food & Beverage

Scandia Inc. (OTC: SDNI) has acquired a majority equity stake in Xtreme Organics Inc. to expand into the medicinal chemicals and botanical products market, including USDA-certified organic hemp supplements and CBG sports beverages. The acquisition brings Xtreme Organics' product portfolio and athlete-focused partnerships under Scandia's public company platform to support U.S. market growth and future expansion into Canada and Latin America.

Cannabinoid Biosciences Acquires CannabidiolHemp

November 25, 2019

Consumer Products

Cannabinoid Biosciences, Inc., a California-based biopharmaceutical subsidiary of Kid Castle, has acquired CannabidiolHemp (CannabidiolHemp.net), a CBD quality aggregator and validator. The purchase is the first of multiple planned acquisitions intended to build a vertically integrated CBD distribution and supply-chain business across the United States and Canada.